• About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact
About About

About

Abcuro.com

Breakthrough Therapies for Autoimmune Diseases & Cancer

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact

Balogh, Peter

September 1, 2026

Peter Balogh is an Analyst with the Investment team at RA Capital Management. Peter’s primary responsibilities are to conduct due diligence on biotechnology companies and advise RA Capital’s portfolio companies on many aspects of program and pipeline strategy. Peter holds a BS in Biology from the University of North Carolina at Chapel Hill.

Peter Balogh

Observer
Analyst, RA Capital

x

Peter Balogh

Observer
Analyst, RA Capital

Peter Balogh is an Analyst with the Investment team at RA Capital Management. Peter’s primary responsibilities are to conduct due diligence on biotechnology companies and advise RA Capital’s portfolio companies on many aspects of program and pipeline strategy. Peter holds a BS in Biology from the University of North Carolina at Chapel Hill.

Privacy Terms of Use

© 2026 Abcuro